LOC100131096: A Drug Target / Disease Biomarker (G100131096)
LOC100131096: A Drug Target / Disease Biomarker
LOC100131096 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the heat shock protein (HSP) family, which are proteins that are expressed in high abundance in response to increased levels of thermal stress.
One of the functions of HSPs is to help cells withstand the damage caused by stress, such as heat, cold, and certain toxins. HSPs can also play a role in the regulation of cellular processes that are important for maintaining tissue homeostasis, including the production and degradation of other proteins.
LOC100131096 is of particular interest as a potential drug target because it is involved in a number of important cellular processes that are relevant to a wide range of diseases. For example, HSPs have been implicated in a number of neurodegenerative diseases, including Alzheimer's and Parkinson's diseases, as well as in the development of certain cancers.
In addition to its potential clinical applications, LOC100131096 is also of interest to researchers because of its well- conserved sequence. This is important because many drugs that are currently being developed to treat human diseases target specific proteins that are similar to LOC100131096, which can make it difficult to predict how a drug will interact with the protein.
Overall, LOC100131096 is a protein that is worth further investigation as a potential drug target. Its well- conserved sequence and its involvement in important cellular processes make it a promising target for researchers to study.
Protein Name: Uncharacterized LOC100131096
The "LOC100131096 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC100131096 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
LOC100131107 | LOC100131257 | LOC100131289 | LOC100131372 | LOC100131496 | LOC100131532 | LOC100131626 | LOC100131635 | LOC100131859 | LOC100131877 | LOC100131943 | LOC100132004 | LOC100132062 | LOC100132077 | LOC100132078 | LOC100132249 | LOC100132287 | LOC100132356 | LOC100132609 | LOC100132626 | LOC100132651 | LOC100132686 | LOC100132741 | LOC100132781 | LOC100132797 | LOC100133077 | LOC100133165 | LOC100133177 | LOC100133284 | LOC100133331 | LOC100133920 | LOC100134317 | LOC100134368 | LOC100134391 | LOC100134868 | LOC100190986 | LOC100233156 | LOC100240728 | LOC100240734 | LOC100240735 | LOC100271840 | LOC100272216 | LOC100272217 | LOC100286922 | LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474
